カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の抗ヘビ毒血清(ASVS)市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Anti Snake Venom Serum (ASVS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19137）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19137
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の抗ヘビ毒血清(ASVS)市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

抗ヘビ毒血清(ASVS)市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の抗ヘビ毒血清(ASVS)の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

抗ヘビ毒血清(ASVS)市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・多価、一価

用途別セグメントは次のように区分されます。
・病院・診療所、非営利団体

世界の抗ヘビ毒血清(ASVS)市場の主要な市場プレーヤーは以下のとおりです。
・CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、抗ヘビ毒血清(ASVS)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗ヘビ毒血清(ASVS)メーカーの企業概要、2019年～2022年までの抗ヘビ毒血清(ASVS)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗ヘビ毒血清(ASVS)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別抗ヘビ毒血清(ASVS)の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの抗ヘビ毒血清(ASVS)の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗ヘビ毒血清(ASVS)市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および抗ヘビ毒血清(ASVS)の産業チェーンを掲載しています。
・第13、14、15章では、抗ヘビ毒血清(ASVS)の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 抗ヘビ毒血清(ASVS)の概要
- 種類別分析（2017年vs2021年vs2028年）：多価、一価
- 用途別分析（2017年vs2021年vs2028年）：病院・診療所、非営利団体
- 世界の抗ヘビ毒血清(ASVS)市場規模・予測
- 世界の抗ヘビ毒血清(ASVS)生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：多価、一価
・用途別分析2017年-2028年：病院・診療所、非営利団体
・抗ヘビ毒血清(ASVS)の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗ヘビ毒血清(ASVS)のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗ヘビ毒血清(ASVS)のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗ヘビ毒血清(ASVS)の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・抗ヘビ毒血清(ASVS)の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Anti Snake Venom Serum (ASVS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti Snake Venom Serum (ASVS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and Clinics accounting for % of the Anti Snake Venom Serum (ASVS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polyvalent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti Snake Venom Serum (ASVS) include CSL, Merck, BTG, Pfizer, and Haffkine Bio-Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti Snake Venom Serum (ASVS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyvalent
Monovalent
Market segment by Application can be divided into
Hospitals and Clinics
Non-profit Institutions
The key market players for global Anti Snake Venom Serum (ASVS) market are listed below:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti Snake Venom Serum (ASVS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti Snake Venom Serum (ASVS), with price, sales, revenue and global market share of Anti Snake Venom Serum (ASVS) from 2019 to 2022.
Chapter 3, the Anti Snake Venom Serum (ASVS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti Snake Venom Serum (ASVS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti Snake Venom Serum (ASVS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti Snake Venom Serum (ASVS).
Chapter 13, 14, and 15, to describe Anti Snake Venom Serum (ASVS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Anti Snake Venom Serum (ASVS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti Snake Venom Serum (ASVS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti Snake Venom Serum (ASVS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Global Anti Snake Venom Serum (ASVS) Market Size & Forecast
1.4.1 Global Anti Snake Venom Serum (ASVS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti Snake Venom Serum (ASVS) Sales in Volume (2017-2028)
1.4.3 Global Anti Snake Venom Serum (ASVS) Price (2017-2028)
1.5 Global Anti Snake Venom Serum (ASVS) Production Capacity Analysis
1.5.1 Global Anti Snake Venom Serum (ASVS) Total Production Capacity (2017-2028)
1.5.2 Global Anti Snake Venom Serum (ASVS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti Snake Venom Serum (ASVS) Market Drivers
1.6.2 Anti Snake Venom Serum (ASVS) Market Restraints
1.6.3 Anti Snake Venom Serum (ASVS) Trends Analysis
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Anti Snake Venom Serum (ASVS) Product and Services
2.1.4 CSL Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Anti Snake Venom Serum (ASVS) Product and Services
2.2.4 Merck Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BTG
2.3.1 BTG Details
2.3.2 BTG Major Business
2.3.3 BTG Anti Snake Venom Serum (ASVS) Product and Services
2.3.4 BTG Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Anti Snake Venom Serum (ASVS) Product and Services
2.4.4 Pfizer Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Rare Disease Therapeutics
2.6.1 Rare Disease Therapeutics Details
2.6.2 Rare Disease Therapeutics Major Business
2.6.3 Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Product and Services
2.6.4 Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Flynn Pharma
2.7.1 Flynn Pharma Details
2.7.2 Flynn Pharma Major Business
2.7.3 Flynn Pharma Anti Snake Venom Serum (ASVS) Product and Services
2.7.4 Flynn Pharma Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Vins Bioproducts
2.8.1 Vins Bioproducts Details
2.8.2 Vins Bioproducts Major Business
2.8.3 Vins Bioproducts Anti Snake Venom Serum (ASVS) Product and Services
2.8.4 Vins Bioproducts Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bharat Serums and Vaccines
2.9.1 Bharat Serums and Vaccines Details
2.9.2 Bharat Serums and Vaccines Major Business
2.9.3 Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Product and Services
2.9.4 Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Serum Biotech
2.10.1 Serum Biotech Details
2.10.2 Serum Biotech Major Business
2.10.3 Serum Biotech Anti Snake Venom Serum (ASVS) Product and Services
2.10.4 Serum Biotech Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MicroPharm
2.11.1 MicroPharm Details
2.11.2 MicroPharm Major Business
2.11.3 MicroPharm Anti Snake Venom Serum (ASVS) Product and Services
2.11.4 MicroPharm Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti Snake Venom Serum (ASVS) Breakdown Data by Manufacturer
3.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti Snake Venom Serum (ASVS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti Snake Venom Serum (ASVS)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti Snake Venom Serum (ASVS) Manufacturer Market Share in 2021
3.4.2 Top 6 Anti Snake Venom Serum (ASVS) Manufacturer Market Share in 2021
3.5 Global Anti Snake Venom Serum (ASVS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti Snake Venom Serum (ASVS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti Snake Venom Serum (ASVS) Market Size by Region
4.1.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Region (2017-2028)
4.1.2 Global Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2028)
4.2 North America Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.3 Europe Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.4 Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.5 South America Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.6 Middle East and Africa Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Type (2017-2028)
5.2 Global Anti Snake Venom Serum (ASVS) Revenue by Type (2017-2028)
5.3 Global Anti Snake Venom Serum (ASVS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Application (2017-2028)
6.2 Global Anti Snake Venom Serum (ASVS) Revenue by Application (2017-2028)
6.3 Global Anti Snake Venom Serum (ASVS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
7.2 North America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
7.3 North America Anti Snake Venom Serum (ASVS) Market Size by Country
7.3.1 North America Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
7.3.2 North America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
8.2 Europe Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
8.3 Europe Anti Snake Venom Serum (ASVS) Market Size by Country
8.3.1 Europe Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
9.2 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
9.3 Asia-Pacific Anti Snake Venom Serum (ASVS) Market Size by Region
9.3.1 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
10.2 South America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
10.3 South America Anti Snake Venom Serum (ASVS) Market Size by Country
10.3.1 South America Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
10.3.2 South America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
11.2 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
11.3 Middle East & Africa Anti Snake Venom Serum (ASVS) Market Size by Country
11.3.1 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti Snake Venom Serum (ASVS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti Snake Venom Serum (ASVS)
12.3 Anti Snake Venom Serum (ASVS) Production Process
12.4 Anti Snake Venom Serum (ASVS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti Snake Venom Serum (ASVS) Typical Distributors
13.3 Anti Snake Venom Serum (ASVS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Anti Snake Venom Serum (ASVS) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti Snake Venom Serum (ASVS) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CSL Basic Information, Manufacturing Base and Competitors
Table 4. CSL Major Business
Table 5. CSL Anti Snake Venom Serum (ASVS) Product and Services
Table 6. CSL Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Anti Snake Venom Serum (ASVS) Product and Services
Table 10. Merck Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. BTG Basic Information, Manufacturing Base and Competitors
Table 12. BTG Major Business
Table 13. BTG Anti Snake Venom Serum (ASVS) Product and Services
Table 14. BTG Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Anti Snake Venom Serum (ASVS) Product and Services
Table 18. Pfizer Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Haffkine Bio-Pharmaceutical Major Business
Table 21. Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Product and Services
Table 22. Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Rare Disease Therapeutics Major Business
Table 25. Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Product and Services
Table 26. Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Flynn Pharma Major Business
Table 29. Flynn Pharma Anti Snake Venom Serum (ASVS) Product and Services
Table 30. Flynn Pharma Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table 32. Vins Bioproducts Major Business
Table 33. Vins Bioproducts Anti Snake Venom Serum (ASVS) Product and Services
Table 34. Vins Bioproducts Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table 36. Bharat Serums and Vaccines Major Business
Table 37. Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Product and Services
Table 38. Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 40. Serum Biotech Major Business
Table 41. Serum Biotech Anti Snake Venom Serum (ASVS) Product and Services
Table 42. Serum Biotech Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. MicroPharm Basic Information, Manufacturing Base and Competitors
Table 44. MicroPharm Major Business
Table 45. MicroPharm Anti Snake Venom Serum (ASVS) Product and Services
Table 46. MicroPharm Anti Snake Venom Serum (ASVS) Sales (USD/Vial), Price (), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Anti Snake Venom Serum (ASVS) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (USD/Vial)
Table 48. Global Anti Snake Venom Serum (ASVS) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Anti Snake Venom Serum (ASVS), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Anti Snake Venom Serum (ASVS) Production Capacity by Company, (USD/Vial): 2020 VS 2021
Table 51. Head Office and Anti Snake Venom Serum (ASVS) Production Site of Key Manufacturer
Table 52. Anti Snake Venom Serum (ASVS) New Entrant and Capacity Expansion Plans
Table 53. Anti Snake Venom Serum (ASVS) Mergers & Acquisitions in the Past Five Years
Table 54. Global Anti Snake Venom Serum (ASVS) Sales by Region (2017-2022) & (USD/Vial)
Table 55. Global Anti Snake Venom Serum (ASVS) Sales by Region (2023-2028) & (USD/Vial)
Table 56. Global Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Anti Snake Venom Serum (ASVS) Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 59. Global Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 60. Global Anti Snake Venom Serum (ASVS) Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Anti Snake Venom Serum (ASVS) Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Anti Snake Venom Serum (ASVS) Price by Type (2017-2022) & ()
Table 63. Global Anti Snake Venom Serum (ASVS) Price by Type (2023-2028) & ()
Table 64. Global Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 65. Global Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 66. Global Anti Snake Venom Serum (ASVS) Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Anti Snake Venom Serum (ASVS) Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Anti Snake Venom Serum (ASVS) Price by Application (2017-2022) & ()
Table 69. Global Anti Snake Venom Serum (ASVS) Price by Application (2023-2028) & ()
Table 70. North America Anti Snake Venom Serum (ASVS) Sales by Country (2017-2022) & (USD/Vial)
Table 71. North America Anti Snake Venom Serum (ASVS) Sales by Country (2023-2028) & (USD/Vial)
Table 72. North America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Anti Snake Venom Serum (ASVS) Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 75. North America Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 76. North America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 77. North America Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 78. Europe Anti Snake Venom Serum (ASVS) Sales by Country (2017-2022) & (USD/Vial)
Table 79. Europe Anti Snake Venom Serum (ASVS) Sales by Country (2023-2028) & (USD/Vial)
Table 80. Europe Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Anti Snake Venom Serum (ASVS) Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 83. Europe Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 84. Europe Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 85. Europe Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 86. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Region (2017-2022) & (USD/Vial)
Table 87. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Region (2023-2028) & (USD/Vial)
Table 88. Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 91. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 92. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 93. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 94. South America Anti Snake Venom Serum (ASVS) Sales by Country (2017-2022) & (USD/Vial)
Table 95. South America Anti Snake Venom Serum (ASVS) Sales by Country (2023-2028) & (USD/Vial)
Table 96. South America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Anti Snake Venom Serum (ASVS) Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 99. South America Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 100. South America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 101. South America Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 102. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Region (2017-2022) & (USD/Vial)
Table 103. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Region (2023-2028) & (USD/Vial)
Table 104. Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Type (2017-2022) & (USD/Vial)
Table 107. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Type (2023-2028) & (USD/Vial)
Table 108. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Application (2017-2022) & (USD/Vial)
Table 109. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Application (2023-2028) & (USD/Vial)
Table 110. Anti Snake Venom Serum (ASVS) Raw Material
Table 111. Key Manufacturers of Anti Snake Venom Serum (ASVS) Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Anti Snake Venom Serum (ASVS) Typical Distributors
Table 115. Anti Snake Venom Serum (ASVS) Typical Customers
List of Figures
Figure 1. Anti Snake Venom Serum (ASVS) Picture
Figure 2. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Type in 2021
Figure 3. Polyvalent
Figure 4. Monovalent
Figure 5. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Application in 2021
Figure 6. Hospitals and Clinics
Figure 7. Non-profit Institutions
Figure 8. Global Anti Snake Venom Serum (ASVS) Revenue, (USD Million) & (USD/Vial): 2017 & 2021 & 2028
Figure 9. Global Anti Snake Venom Serum (ASVS) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Anti Snake Venom Serum (ASVS) Sales (2017-2028) & (USD/Vial)
Figure 11. Global Anti Snake Venom Serum (ASVS) Price (2017-2028) & ()
Figure 12. Global Anti Snake Venom Serum (ASVS) Production Capacity (2017-2028) & (USD/Vial)
Figure 13. Global Anti Snake Venom Serum (ASVS) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Anti Snake Venom Serum (ASVS) Market Drivers
Figure 15. Anti Snake Venom Serum (ASVS) Market Restraints
Figure 16. Anti Snake Venom Serum (ASVS) Market Trends
Figure 17. Global Anti Snake Venom Serum (ASVS) Sales Market Share by Manufacturer in 2021
Figure 18. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Manufacturer in 2021
Figure 19. Anti Snake Venom Serum (ASVS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Anti Snake Venom Serum (ASVS) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Anti Snake Venom Serum (ASVS) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Anti Snake Venom Serum (ASVS) Sales Market Share by Region (2017-2028)
Figure 23. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Region (2017-2028)
Figure 24. North America Anti Snake Venom Serum (ASVS) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Anti Snake Venom Serum (ASVS) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue (2017-2028) & (USD Million)
Figure 27. South America Anti Snake Venom Serum (ASVS) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue (2017-2028) & (USD Million)
Figure 29. Global Anti Snake Venom Serum (ASVS) Sales Market Share by Type (2017-2028)
Figure 30. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Type (2017-2028)
Figure 31. Global Anti Snake Venom Serum (ASVS) Price by Type (2017-2028) & ()
Figure 32. Global Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 33. Global Anti Snake Venom Serum (ASVS) Revenue Market Share by Application (2017-2028)
Figure 34. Global Anti Snake Venom Serum (ASVS) Price by Application (2017-2028) & ()
Figure 35. North America Anti Snake Venom Serum (ASVS) Sales Market Share by Type (2017-2028)
Figure 36. North America Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 37. North America Anti Snake Venom Serum (ASVS) Sales Market Share by Country (2017-2028)
Figure 38. North America Anti Snake Venom Serum (ASVS) Revenue Market Share by Country (2017-2028)
Figure 39. United States Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Anti Snake Venom Serum (ASVS) Sales Market Share by Type (2017-2028)
Figure 43. Europe Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 44. Europe Anti Snake Venom Serum (ASVS) Sales Market Share by Country (2017-2028)
Figure 45. Europe Anti Snake Venom Serum (ASVS) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Anti Snake Venom Serum (ASVS) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue Market Share by Region (2017-2028)
Figure 55. China Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Anti Snake Venom Serum (ASVS) Sales Market Share by Type (2017-2028)
Figure 62. South America Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 63. South America Anti Snake Venom Serum (ASVS) Sales Market Share by Country (2017-2028)
Figure 64. South America Anti Snake Venom Serum (ASVS) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Anti Snake Venom Serum (ASVS) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Anti Snake Venom Serum (ASVS) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Anti Snake Venom Serum (ASVS) in 2021
Figure 76. Manufacturing Process Analysis of Anti Snake Venom Serum (ASVS)
Figure 77. Anti Snake Venom Serum (ASVS) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の牛胎児血清（FCS）市場2022年：市場規模予測（～2028年）
  • 世界のトップ反射防止コーティング剤（TARC）市場2022年：市場規模予測（～2028年）
  • 世界のワックス沈降防止添加剤（WASA）市場2022年：市場規模予測（～2028年）
  • 世界のボトム反射防止コーティング剤 (BARC)市場2022年：市場規模予測（～2028年）
  • 世界のウマ狂犬病免疫グロブリン（ERIG）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19137 )"世界の抗ヘビ毒血清(ASVS)市場2022年：市場規模予測（～2028年）" (英文：Global Anti Snake Venom Serum (ASVS) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。